China News Service, February 6 (China News Business Reporter Xie Yiguan) On February 6, the three major A-share stock indexes collectively rose in early trading, with the Shanghai Stock Exchange Index standing firmly above 2,700 points.
As of the midday close, the Shanghai Stock Exchange Index rose 0.82% to 2724.26 points; the Shenzhen Component Index rose 3.13% to 8214.33 points; the ChiNext Index rose 3.38% to 1615.39 points.
The three major A-share stock indexes closed at noon.
On the market, most industry sectors were in the red, with the pharmaceutical sector leading the gains, and related stocks such as Yabao Pharmaceutical, Wantai Biotech, Ganli Pharmaceuticals, etc. reaching their daily limit. In addition, chemical fiber, medical care, engineering machinery, aviation, brewing and other industry sectors were also among the top gainers. In terms of concept sectors, vitamins, cobalt metal, new energy vehicles and other sectors performed well.
The industry sectors with the largest gains.
The concept sector with the highest growth rate.
The pharmaceutical sector was the top gainer.
Judging from the turnover, market trading enthusiasm showed, with the Shanghai and Shenzhen stock exchanges trading 484.6 billion yuan in half a day. Northbound funds actively entered the market, with net purchases exceeding 4 billion yuan in early trading. In addition, ETF trading was active in early trading, and many CSI 1000 ETFs saw significant volume.
On February 6, Central Huijin issued an announcement stating that it fully recognized the current allocation value of the A-share market and had recently expanded the scope of holdings of exchange-traded open-end index funds (ETFs), and would continue to increase its holdings and expand its holdings. scale and resolutely maintain the smooth operation of the capital market.
Screenshot of Central Huijin’s official website.
On the same day, the spokesperson of the China Securities Regulatory Commission responded to reporters’ questions about Central Huijin’s announcement on increasing its holdings, saying that we have paid attention to Central Huijin’s announcement. Currently, the valuation level of the A-share market is at a historically low level, and the medium- and long-term investment value has been highlighted, which has been fully recognized by investment institutions including Central Huijin. We firmly support Central Huijin to continue to increase the scale and intensity of its holdings, and will create more convenient conditions and smoother channels for its market entry operations.
“At the same time, we will continue to coordinate and guide various institutional investors such as public funds, private equity funds, securities companies, social security funds, insurance institutions, and annuity funds to enter the market with greater efforts, encourage and support listed companies to increase their repurchases and increase their holdings, and provide The A-share market will introduce more incremental funds and make every effort to maintain the stable operation of the market," said a spokesman for the China Securities Regulatory Commission. (over)